NANOMICRO: Blood products are listed as a key application direction for chromatography fillers in core business

Zhitong
2025.09.22 11:57

On September 22, NANOMICRO disclosed the record of investor relations activities. NANOMICRO stated that in recent years, domestic blood product customers have increasingly emphasized research on innovative processes and the domestic substitution of key materials. The company has included blood products as one of the key application directions in its core business of chromatography fillers "3+2," continuously developing new products and application processes, actively connecting with customer needs, and has introduced R&D projects at different stages

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.